Per Chilstrom

212-430-2669
pchilstrom@fenwick.com
Partner
Corporate

Per
Chilstrom

Per
Chilstrom

Per
Chilstrom

Partner
Corporate

Per has extensive experience in the areas of U.S. domestic and cross-border capital markets, and has acted as issuer’s and underwriter’s counsel on IPOs and follow-on public equity offerings as well as public and private offerings of debt (including high yield and convertible bonds).

Per has significant involvement with numerous industries including healthcare, technology, energy, insurance, consumer products, real estate and specialty finance.

  • Accel Entertainment
  • Bill.com
  • Genenta Science
  • InMobi
  • Materialise
  • Molekule
  • Play Games24x7
  • Sema4
  • SPACES
  • Velo3D
  • WELL Health Technologies

  • Accel Entertainment
  • Bill.com
  • Genenta Science
  • InMobi
  • Materialise
  • Molekule
  • Play Games24x7
  • Sema4
  • SPACES
  • Velo3D
  • WELL Health Technologies

  • Molekule, an air purifier company, on its merger with AeroClean Technologies
  • Sema4, a genomic and clinical data intelligence company, on its acquisition of GeneDx and its de-SPAC transaction with CM Life Sciences
  • Velo3D, a technology company focused on additive manufacturing for high-value metal parts, on its de-SPAC transaction with JAWS Spitfire Acquisition
  • Bill.com, a leading provider of cloud-based software that simplifies, digitizes and automates complex back-office financial operations for businesses, on its concurrent $1.38B public common stock and $575M convertiblesenior notes offerings
  • Proterra, an innovator in commercial vehicle electrification technology, on its de-SPAC transaction with ArcLight Clean Transition
  • Materialise, a Belgian technology company specializing in 3D printing, on its $110M U.S. IPO
  • Quotient, a Jersey, Channel Islands transfusion diagnostics company, on its $40M U.S. IPO
  • Bank of America Merrill Lynch and Piper Jaffray as underwriters on Tandem Diabetes Care’s $138M U.S. IPO
  • Watford Holdings, a Bermuda based insurance company, on the direct listing of its common shares (the first ever direct listing on the Nasdaq)

  • Molekule, an air purifier company, on its merger with AeroClean Technologies
  • Sema4, a genomic and clinical data intelligence company, on its acquisition of GeneDx and its de-SPAC transaction with CM Life Sciences
  • Velo3D, a technology company focused on additive manufacturing for high-value metal parts, on its de-SPAC transaction with JAWS Spitfire Acquisition
  • Bill.com, a leading provider of cloud-based software that simplifies, digitizes and automates complex back-office financial operations for businesses, on its concurrent $1.38B public common stock and $575M convertiblesenior notes offerings
  • Proterra, an innovator in commercial vehicle electrification technology, on its de-SPAC transaction with ArcLight Clean Transition
  • Materialise, a Belgian technology company specializing in 3D printing, on its $110M U.S. IPO
  • Quotient, a Jersey, Channel Islands transfusion diagnostics company, on its $40M U.S. IPO
  • Bank of America Merrill Lynch and Piper Jaffray as underwriters on Tandem Diabetes Care’s $138M U.S. IPO
  • Watford Holdings, a Bermuda based insurance company, on the direct listing of its common shares (the first ever direct listing on the Nasdaq)

Login

Don’t have an account yet?

Register